Investor Update

Basel, 11 September 2019

Reminder: Invitation to Roche’s Pharma Day - Monday, 16th September 2019

The Roche Investor Relations team would like to invite you to the Roche Pharma Day that will take place in London on Monday, 16th September 2019, starting at 9:30am local time.

Presentations will be held in the morning, followed by lunch and breakout sessions in the afternoon. The event will finish at 2:45pm local time with a buffet reception held afterwards.

The Roche Pharma Day will address the following topics:

Bill Anderson: Pharma strategy, Portfolio planning, Productivity and new technologies
Teresa Graham: Market opportunities; Pricing & Access
Sandra Horning: Late stage pipeline Oncology
Paulo Fontoura: Late stage pipeline Neuroscience

Break Out sessions (afternoon- will not be webcasted)
Cristin Hubbard / Zafar Hakim: Late stage pipeline Immunology & Infectious diseases
Atul Dandekar / Sascha Fauser: Late stage pipeline Ophthalmology
Bryn Roberts: Digitalisation & Personalized healthcare


The event will focus on the overall Pharma strategy including digitalisation and PHC and will also update on the most recent pivotal Phase III studies initiated including NMEs just moved to late stage development.

You will have the opportunity to meet all senior management during the event.

Presentations will also be publicly available via a live video webcast on

Meeting information:
Date/Time (BST):

Monday, 16th September 2019
09:00am Registration
09:30am Event starts
2:45pm Event ends
followed by a buffet reception

Hilton London Tower Bridge
5 More London Place
Tooley Street, London

To register for the event please follow this link

Alternatively, you may dial in to the conference.
To expedite the registration process on the day of the event, please pre-register for the conference call, click here, or dial in using the following dial-in numbers (listen-only mode, no live-access to speakers), 10-15 minutes prior to the scheduled start:

+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 207 107 0613 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

A replay of the webcast will be available on demand at